| Name | 3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione |
|---|---|
| Synonyms |
2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole
tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione dimiracetam 1H-Pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione,dihydro (+-)-Dihydro-1H-pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione Dimiracetam [INN] |
| Description | Dimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neurological alterations, and inhibits Sorafenib (HY-10201)-induced neuropathy in cold stimulation rat models[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4g/cm3 |
|---|---|
| Boiling Point | 460.5ºC at 760 mmHg |
| Molecular Formula | C6H8N2O2 |
| Molecular Weight | 140.14 |
| Flash Point | 232.3ºC |
| Exact Mass | 140.05900 |
| PSA | 52.90000 |
| Vapour Pressure | 1.16E-08mmHg at 25°C |
| Index of Refraction | 1.585 |
|
~82%
126100-97-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
|
~22%
126100-97-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |